89BIO (ETNB)
(Delayed Data from NSDQ)
$8.86 USD
+0.39 (4.55%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $8.85 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for 89BIO falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -142.19 | -102.03 | -90.12 | -49.50 | -57.42 |
Depreciation/Amortization & Depletion | -5.32 | -0.15 | 1.56 | 0.56 | 0.02 |
Net Change from Assets/Liabilities | 0.66 | 10.56 | 3.25 | -1.04 | 0.94 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 17.66 | 10.53 | 8.53 | 3.74 | 31.01 |
Net Cash From Operating Activities | -129.19 | -81.09 | -76.78 | -46.24 | -25.46 |
Property & Equipment | 0.00 | -0.01 | -0.06 | -0.13 | -0.14 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -123.02 | -33.94 | 7.22 | -106.71 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -123.02 | -33.94 | 7.16 | -106.83 | -0.14 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 512.42 | 118.13 | 3.92 | 158.09 | 107.69 |
Issuance (Repayment) of Debt | 2.96 | 0.00 | 19.95 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.28 | -0.30 | 0.00 | -0.16 | 0.00 |
Net Cash from Financing Activities | 513.11 | 117.83 | 23.87 | 157.92 | 107.70 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 260.91 | 2.80 | -45.75 | 4.85 | 82.10 |
Cash at Beginning of Period | 55.26 | 52.46 | 98.21 | 93.36 | 11.26 |
Cash at End of Period | 316.16 | 55.26 | 52.46 | 98.21 | 93.36 |
Diluted Net EPS | -2.00 | -2.93 | -4.48 | -3.08 | -24.49 |
Fiscal Year End for 89BIO falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -99.65 | -51.68 | -142.19 | -101.95 | -67.23 |
Depreciation/Amortization & Depletion | -5.06 | 0.17 | -5.32 | -3.85 | -1.89 |
Net Change from Assets/Liabilities | -6.81 | 9.44 | 0.66 | -2.77 | -4.57 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10.63 | 2.35 | 17.66 | 13.69 | 9.16 |
Net Cash From Operating Activities | -100.88 | -39.72 | -129.19 | -94.89 | -64.53 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -52.05 | -79.90 | -123.02 | -59.38 | -97.70 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -52.05 | -79.90 | -123.02 | -59.38 | -97.70 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 50.83 | 22.97 | 512.42 | 350.27 | 350.15 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 2.96 | 2.96 | 2.96 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -1.84 | -1.94 | -2.28 | -2.29 | -0.69 |
Net Cash from Financing Activities | 48.99 | 21.03 | 513.11 | 350.94 | 352.42 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -103.94 | -98.59 | 260.91 | 196.67 | 190.19 |
Cash at Beginning of Period | 316.16 | 316.16 | 55.26 | 55.26 | 55.26 |
Cash at End of Period | 212.22 | 217.57 | 316.16 | 251.93 | 245.44 |
Diluted Net EPS | -0.48 | -0.54 | -0.49 | -0.45 | -0.52 |